Related compounds
Buffer solution, Tetramethylammonium hydroxide solution, and 0.1 M Edetate disodium solution
Proceed as directed in the Assay.
Solution A
To 1000 mL of Tetramethylammonium hydroxide solution add 0.4 mL of 0.1 M Edetate disodium solution, filter, and degas.
Solution B
To 500 mL of Tetramethylammonium hydroxide solution add 300 mL of acetonitrile, 200 mL of methanol, and 0.4 mL of 0.1 M Edetate disodium solution. Filter and degas.
Mobile phase
Use variable mixtures of
Solution A and
Solution B as directed for
Chromatographic system. Make adjustments if necessary (see
System Suitability under
Chromatography
621
).
System suitability solution A
Transfer 1 mL of the Test solution to a 100-mL volumetric flask. Dilute with Tetramethylammonium hydroxide solution to volume, and mix.
System suitability solution B
Transfer 1 mL of System suitability solution A to a 10-mL volumetric flask. Dilute with Tetramethylammonium hydroxide solution to volume, and mix.
System suitability solution C
Transfer about 30 mg of USP Cefdinir RS and 2 mg of USP Cefdinir Related Compound A RS to a 20-mL volumetric flask, dissolve in 3 mL of Buffer solution, dilute with Tetramethylammonium hydroxide solution to volume, and mix.
Test solution
Transfer about 100 mg of Cefdinir, accurately weighed, to a 10-mL volumetric flask, dissolve in and dilute with Buffer solution to volume, and mix. Transfer 3 mL of this solution to a 20-mL volumetric flask, dilute with Tetramethylammonium hydroxide solution to volume, and mix.
[noteInject this solution immediately.]
Chromatographic system (see Chromatography
621
)
The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 15-cm column that contains packing L1. The column temperature is maintained at 40

. The flow rate is about 1 mL per minute. The chromatograph is programmed as follows.
Time (minutes) |
Solution A
(%) |
Solution B
(%) |
Elution |
02 |
95 |
5 |
isocratic |
222 |
95®75 |
5®25 |
linear gradient |
2232 |
75®50 |
25®50 |
linear gradient |
3237 |
50 |
50 |
isocratic |
3738 |
50®95 |
50®5 |
linear gradient |
3858 |
95 |
5 |
isocratic |
Chromatograph
System suitability solution A and
System suitability solution B, and record the peak responses as directed for
Procedure: the peak response of cefdinir in
System suitability solution B is about 7% to 13% of that obtained from
System suitability solution A. Chromatograph
System suitability solution C, and record the peak responses as directed for
Procedure: cefdinir related compound A elutes with four peaks. The relative retention times are not less than 1.1 for the third peak of cefdinir related compound A and 1.0 for cefdinir; the column efficiency, determined from the cefdinir peak, is not less than 7000 theoretical plates; the tailing factor for the cefdinir peak is not more than 3.0; and the relative standard deviation for replicate injections, based on the cefdinir peak, is not more than 2.0%.
Procedure
Inject a volume (about 10 µL) of the
Test solution into the chromatograph, record the chromatogram, and measure all the peak responses. Continue the chromatogram for 40 minutes. Calculate the percentage of each impurity in the portion of Cefdinir taken by the formula:
100(ri / rs)
in which
ri is the peak response for each impurity, and
rs is the sum of the responses of all the peaks. The limits for the impurities are specified in
Table 1.
Table 1
Impurity |
Relative Retention Time |
Limit (w/w, %) |
Impurity A1 |
0.10 |
0.5 |
Impurity B2 |
0.12 |
0.5 |
Impurity C3 |
0.74 |
0.7 |
Cefdinir related compound A (4 peaks)4 |
0.85, 0.93, 1.11, 1.14 |
0.7 (total for all 4 peaks) |
Impurity E5 |
1.22 |
0.5 |
Impurity F6 |
1.36 |
0.5 |
Impurity G7 |
1.51 |
0.7 |
Impurity H (2 peaks)8 |
1.61, 1.64 |
0.5 (total for both peaks) |
Individual unknown impurity |
|
0.2 |
Total impurities |
|
3.0 |
1
N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine.
2
(Z)-2-(2-Aminothiazol-4-yl)-N-(2,2-dihydroxyethyl)-2-(hydroxyimino)acetamide.
3
(6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid.
4
2(R)-2-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid.
5
(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)-N-{(3RS,5aR,6R)-3-methyl-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}acetamide.
6
(6R,7R)-7-(4-hydroxyisoxazole-3-carboxamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid.
7
(6R,7R)-7-[(E)-2-(2-Aminothiazol-4-yl-)-2-(hydroxyimino)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid.
8
(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)-N-{[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]methyl}acetamide.
|
Assay
Buffer solution
Dissolve about 7.1 g of anhydrous dibasic sodium phosphate in 500 mL of water (Solution A). Dissolve about 6.8 g of monobasic potassium phosphate in 500 mL of water (Solution B). Add appropriate amounts of Solution A and Solution B (approximately 2:1 v/v) to obtain a mixture having a pH of 7.0.
Tetramethylammonium hydroxide solution
To 10 mL of tetramethylammonium hydroxide (10%) add 990 mL of water, and adjust with dilute phosphoric acid (1 in 10) to a pH of 5.5.
0.1 M Edetate disodium solution
Dissolve 37.2 g of edetate disodium in 1000 mL of water, and mix.
Mobile phase
Prepare a filtered and degassed mixture of
Tetramethylammonium hydroxide solution, acetonitrile, methanol, and
0.1 M Edetate disodium solution (900:60:40:0.4). Make adjustments if necessary (see
System Suitability under
Chromatography
621
).
System suitability solution
Dissolve accurately weighed quantities of USP Cefdinir RS and USP Cefdinir Related Compound A RS in Buffer solution to obtain a solution having a known concentration of about 0.2 mg per mL of USP Cefdinir RS and 0.5 mg per mL of USP Cefdinir Related Compound A RS.
Standard preparation
Dissolve an accurately weighed quantity of USP Cefdinir RS in Buffer solution, and dilute quantitatively, and stepwise if necessary, with Buffer solution to obtain a solution having a known concentration of about 0.2 mg per mL.
Assay preparation
Transfer about 20 mg of Cefdinir, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with Buffer solution to volume, and mix well.
Chromatographic system (see Chromatography
621
)
The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 15-cm column that contains 5-µm packing L1. The flow rate is about 1 mL per minute. The column temperature is maintained at 40

. Chromatograph the
System suitability solution, and record the peak responses as directed for
Procedure: cefdinir related compound A elutes with four peaks. The resolution,
R, between the second peak of cefdinir related compound A and cefdinir is not less than 1.2; and the tailing factor for the cefdinir peak is not more than 1.5. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the relative standard deviation for replicate injections is not more than 1.0%.
Procedure
Separately inject equal volumes (about 5 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in µg, of C
14H
13N
5O
5S
2 in each mg of Cefdinir taken by the formula:
P(CS / CU)(rU / rS)
in which
P is the purity, in µg per mg, of USP Cefdinir RS;
CS is the concentration, in mg per mL, of USP Cefdinir RS in the
Standard preparation; CU is the concentration, in mg per mL, of Cefdinir in the
Assay preparation; and
rU and
rS are the peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.
USP32